Skip to main content
Hindustan Composites Ltd logo

Hindustan Composites Ltd — Investor Relations & Filings

Ticker · HINDCOMPOS ISIN · INE310C01029 LEI · 3358003O8M114SW7U738 BSE.NS Manufacturing
Open in API
Filings indexed 1,157 across all filing types
Latest filing 2026-04-20 Regulatory Filings
Country IN India
Listing BSE.NS HINDCOMPOS

About Hindustan Composites Ltd

https://www.hindcompo.com

Hindustan Composites Ltd is a prominent manufacturer and supplier of high-performance friction materials. The company specializes in the development and production of a comprehensive range of products, including brake linings, clutch facings, disc brake pads, roll linings, and brake blocks. These components are engineered for critical applications across the automotive, railway, engineering, mining, and aerospace sectors. Serving both original equipment manufacturers (OEMs) and the aftermarket, the company utilizes advanced research and development to ensure product safety and durability. Its portfolio includes industrial friction solutions and specialized composite materials designed for heavy-duty vehicles, passenger cars, and industrial machinery. With a focus on technical excellence and innovation, the company provides essential friction solutions for diverse mechanical systems.

Recent filings

Filing Released Lang Actions
Reply to Clarification- Financial results
Regulatory Filings Classification · 95% confidence The document is a letter dated 24th June 2025 addressed to the National Stock Exchange of India Limited. It is a clarification response regarding the financial results submitted by the company for the quarter and financial year ended 31st March 2025. The letter addresses a specific observation from the exchange about the format of the financial results and explains the treatment of joint venture losses and differences in segment assets and liabilities between standalone and consolidated results. The document is short (2256 characters) and serves as a regulatory clarification or compliance communication rather than the financial results report itself. It does not contain actual financial statements or detailed financial data but is a response to a regulatory query about previously submitted financial results. Therefore, it fits best under Regulatory Filings (RNS) as a compliance clarification letter rather than an Interim Report (IR) or Earnings Release (ER).
2026-04-20 English
Price movement
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) responding to their query about significant price movement of the company's stock. It clarifies that the price movement is market-driven and states compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. There is no financial data, no report attached or referenced as being published, and no detailed financial or management information. The document is a regulatory communication responding to a surveillance query, which fits best under Regulatory Filings (RNS). The document length is short (1940 characters), and it is not a report or announcement of a report publication, so it is not RPA. It is not a certification letter either. Therefore, the best classification is Regulatory Filings (RNS).
2026-04-16 English
Clarification in response to the query related to significant price movement in scrip
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges clarifying the reason for significant price movement of the company's stock. It references regulatory compliance under SEBI Listing Regulations and states that the price movement is market-driven. The document is short (1940 characters) and serves as a regulatory communication rather than a financial report or detailed disclosure. It does not contain financial data, management changes, voting results, or other report content. It is a regulatory filing responding to surveillance queries about price movement, fitting the category of Regulatory Filings (RNS).
2026-04-16 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-04-14 English
Board Meeting — Financial Results/Dividend
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying them of an upcoming Board meeting scheduled for April 23, 2026. The agenda includes approval of audited financial results for the quarter and financial year ended March 31, 2026, and recommendation of dividend payment. It also mentions the closure of the trading window for insiders. The document is an announcement of a Board meeting and its agenda, not the actual financial results or reports themselves. It is a regulatory announcement under SEBI regulations about the Board meeting and related compliance matters. Therefore, it fits best under Board/Management Information (MANG) as it relates to Board meeting notification and management decisions. The document length is short (2203 characters), and it does not contain financial statements or detailed results, so it is not an Annual Report or Earnings Release. Confidence is high due to clear regulatory references and content type.
2026-04-14 English
Pursuant to Regulation 29 of the Listing Regulations, Intimation of Board Meeting to inter alia recommend final dividend, if any.
Regulatory Filings Classification · 95% confidence The document is a formal notice addressed to stock exchanges about an upcoming Board meeting scheduled for April 23, 2026. The notice mentions that the Board will consider approving audited financial results for the quarter and financial year ended March 31, 2026, and possibly recommend dividend payment. It also references regulatory compliance under SEBI Listing Obligations and Disclosure Requirements. The document does not contain the financial results themselves but is an announcement of the Board meeting where such results will be approved. The document length is short (2203 characters) and serves as an intimation rather than a full report. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about a Board meeting and upcoming financial results approval, not the financial report itself or a detailed management report.
2026-04-14 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.